skip to Main Content

Program Details

September 2022 - April 2023
Location : Harvard Medical School (Boston, USA)
Program Fee : USD 30,000

Global Health Care Leaders Program

The Global Health Care Leaders Program (GHLP) from Harvard Medical School Executive Education is a first of its kind, multi-modular global program that aims to bring together the most important topics defining the future of health care industry for the leaders who will lead the charge. Faculty from Harvard Medical School, as well as other leading industry experts, will provide insights to enable participants to craft ambitious solutions and shape health care globally.

The health care industry is dynamic and complex. It is experiencing rapid change due to emerging technologies. Established and emerging business leaders and their organizations are recognizing that success in this rapidly evolving industry now requires a fundamental understanding of current medical practices across the world, the changing economic and regulatory landscape of health care and cost vs return on innovation, the latest advances in science and medicine, as well as the threats of evolving pandemics and the prospects of evolving digital technologies and their applications within health care.

GHLP therefore aims to deliver hands on experiences with best practices, strategic frameworks and insights to help global health care leaders to unlock opportunities and drive growth and innovation in health care.

After completion of the GHLP, you will be a part of a global cohort of Health Care leaders. You will become an integral part of the Harvard Medical School Executive Education network. You will also be able to join Harvard Alumni Association (HAA) as an associate member and become a part of an active global network connecting with and supporting each other, facilitating lifelong learning, growth, and success. Following are some of the key benefits*:

  • Global Health Care Leaders Program Certificate from Harvard Medical School
  • A lifelong Harvard alumni email forwarding address
  • Network with members of the Harvard Alumni Association at one of the HAA’s many events held worldwide
  • Connect and network with fellow alumni through the Harvard Alumni Directory
  • Connect to the richly developed network of Harvard alumni by joining one of the 195+ Harvard Clubs in more than 70 countries throughout the world, or one of 51 Shared Interest Groups (SIGs)
  • Access to HAA message boards for alumni to communicate about a variety of topics, including careers. Members can search job postings, career events, career services, and career advice/networking discussion posts
  • Access to select Harvard Medical School events, conferences and seminars
  • Access to select Harvard Medical School online publications such as webinar series etc
  • Access to the GHLP LinkedIn group

* Benefits are subject to change

During the GHLP, you will gain experiential insights into cutting-edge global health care innovation and build a powerful network of Harvard Medical School experts and peer leaders across global health care. Learning objectives include:

  • Apply new insights and program learnings to day-to-day work, as well as long-term strategic priorities, to accelerate innovations that benefit patients and physicians
  • Understand how digital health, AI, emerging technologies, reimbursement changes and other converging forces are shaping the current and future health care ecosystems, and the business models and opportunities that will emerge
  • Strengthen your ability to lead effective change management and drive successful transformation processes within your organization and the health care industry

For more than 200 years, Harvard Medical School (HMS) has shaped the design of medical school education throughout the world while preparing generations of leaders in patient care, education, research and policy. To be a citizen of this community means embracing a collegial spirit that fosters inclusion and promotes achievement.

HMS Executive Education brings the expertise of HMS to executives and organizations that seek to drive growth and innovation in health care. We draw upon the nearly 12,000 faculty from Harvard Medical School to design and deliver impactful programs in medicine, health care economics, genetics, health care policy, advances in biomedical science, patient care and more. In addition to the involvement of HMS faculty, our programs are taught and led by academics from Schools across Harvard University, and by business and science leaders at the forefront of breakthrough innovations in health care. At our home in the iconic HMS Quadrangle in Boston, we are surrounded by several of its world-renowned affiliated hospitals and research institutions. A center of teaching, research and learning, HMS is located on a campus separate from the main Harvard University complex across the Charles River in Cambridge.

Learn More

This program is designed for global health care change-makers, business and science leaders, as well as leaders who are transitioning into the health care field. The program is appropriate for professionals who seek the latest insights into this dynamic and complex industry, in order to become better leaders and innovators in their organization.

Professionals from the following industry segments will benefit from this program:

  • Pharmaceuticals and biotechnology
  • Health IT and digital health
  • Health systems
  • Health insurance and payers
  • Policy and regulatory aspects
  • Professional service firms whose work impacts health care including investing, legal and consulting

The program is suitable for participants with the following qualifications:

  • Significant responsibilities and a demonstrated career progression in a corporate or entrepreneurial environment.
  • Experience in leading teams and managing projects, products, or people preferred but not required.
  • A minimum of 10+ years of work experience.
  • Fluency in written and spoken English.

HMS’s executive-level programs deliver new insights that position business and science leaders to unlock opportunities in a dynamic and rapidly changing health care landscape. We engage business leaders whose work impacts health care and expose them to the real-world practice of medicine, cutting-edge trends in science, clinical workflows and health care delivery.

Learning Approach

Our learning approach is designed for creating high impact. It includes:

  • Interactive classroom discussions with the world-renowned HMS clinical and science faculty.
  • Experiential learning, including field trips to medical and research facilities, health care organizations and innovation hubs, as well as small group projects
  • Time for reflection and networking

World-Renowned Faculty

Our executive education programs are designed and delivered by a world-renowned instructors who are leaders in medicine, health care economics and therapeutics. Our programs also draw upon the expertise of faculty from other Schools at Harvard University and industry-leading practitioners.

Measurable Outcomes

Our participants become highly sophisticated within the domain of health care, developing stronger, forward-thinking business strategies and, ultimately, delivering products and services that improve the lives of providers and—most importantly—patients.

GHLP will incorporate interactive, case-based classroom sessions, immersive exercises that illuminate the challenges of health care, and visits to research labs, innovative companies and other key components of the innovation ecosystem in Boston. These in-person experiences will be supplemented by live virtual sessions and other curated resources at the beginning of the program and between in-person sessions.

Additionally, each participant will identify and work on a project which documents an innovation or process improvement that they will work to implement upon their return to their home countries and home institutions.

The program will focus on following key themes:

Business and science leaders must operate at the complex intersection of trends that are disrupting legacy business models and possess a comprehensive understanding of the health care ecosystem. This is critical for their innovations to succeed and to fulfill important previously unmet needs of patients, providers or payers.

  • Experiences of patients and caregivers, and how patient experiences reveal unmet clinical needs and inspire avenues for research discovery
  • How doctors think: The culture of medicine and patient-doctor interaction
  • Changing the makeup of care teams and care coordination
  • Perspectives from health care in different contexts, from academic medical centers and community to underserved populations
  • Pain points and threats to traditional care delivery models
  • Population health management to maximize value
  • Genetics and precision medicine in clinical practice

Innovation in health care is increasingly multidisciplinary, as AI and big-data analytics create a wealth of insight into the biology of disease, and as cross-functional global teams work to create new diagnostics and therapies.

  • The discovery, tech transfer, company formation and role of local and regional innovation ecosystems
  • The current and future design of clinical trials, and the pathway by which new therapies achieve regulatory approval
  • The digital transformation of drug discovery and development
  • How new medicines become part of clinical practice: how clinicians learn about new therapies and what sources of information clinicians trust
  • Leadership challenges in the academic medical center: How do hospital executives set priorities, navigate industry transformation, and support innovation

There is an increasing wealth of opportunity, as well as challenges at the intersection of technology and health care, as machine learning and other AI technologies are applied to the development of new drugs and as new digital therapeutics hit the market, dramatically transforming care delivery. HMS researchers and clinicians are at the forefront of applying these technologies and understanding both, where opportunity lies and where the hardest problems remain.

  • Digital therapeutics and telehealth: use cases for how digital tools can improve patient access, provide algorithmic disease management, improve adherence, and facilitate smooth transitions of care
  • Innovations in medicine and surgery: state-of-the-art examples of how technology is enhancing outcomes before, during and after surgery or medical procedures

Payers and purchasers are increasingly focused on pricing and value-based reimbursement. At the same time, the complex care delivery workflows associated with many innovative therapies mean that biotech, pharma, device and health care IT companies need to account for the needs and perspectives of patients, clinicians, care teams, administrators and payers to make new products successful.

  • Drug and device development and approval processes and how they vary across the world
  • The current state and future of reimbursement: implications for patients, providers and payers
  • Outcome and treatment disparities: challenges in caring for patients across the socioeconomic spectrum

Innovation is increasingly becoming a multidisciplinary enterprise, both within major global companies and across the ecosystem. Leaders must navigate the complexities presented by competing priorities and internal cultures in pursuit of excellence in innovation.

  • New skill sets and competencies required to develop and deliver new health care products and services
  • Attracting and retaining talent, especially in regional innovation hubs
  • Managing multi-disciplinary teams across geographies

The program will be led by the Harvard Medical School faculty who are leaders and distinguished innovators in their fields. Through their research and clinical practice, they possess broad expertise and cutting-edge knowledge.

HMS Faculty Director

Stanley Shaw, MD, PhD
Faculty Director, GHLP
Associate Dean for Executive Education,
Harvard Medical School

Stanley Y. Shaw, MD, PhD is the Associate Dean for Executive Education at Harvard Medical School. In this role, he designs and directs a growing portfolio of programs for companies and executive leaders from diverse sectors of health care, from small biotechs to Fortune 100 companies. Dr. Shaw is also the Chief Scientific Officer for One Brave Idea (at Brigham and Women’s Hospital), an initiative funded by the American Heart Association, Verily and Astra Zeneca to understand and treat the earliest changes in coronary heart disease. His research seeks to understand how digital health, bioinformatics, the gut microbiome and patient-reported data can be leveraged to better assess health and disease.

Previously, he co-founded the Center for Assessment Technology and Continuous Health (CATCH) at Massachusetts General Hospital, and his team led the development of one of the first ResearchKit iPhone apps in partnership with Apple. Dr. Shaw received his AB in Chemistry & Physics from Harvard College, and his MD and PhD (in Biophysics) from Harvard. He completed his clinical training in Internal Medicine and Cardiology at Massachusetts General Hospital.

View Full Profile

Program faculty may include:*

*Program faculty is subject to change

The Global Health Care Leaders Program (GHLP) follows a rolling admissions (first come, first serve) process. Participant applications are evaluated as soon as they are received. The step-by-step process is outlined below.

Online Application

You can apply to the program online by submitting a short online application form. We do not accept any paper applications.

Apply Here


Keep a resume in word or PDF format ready to be submitted (via upload) along with application form.


We require details of two professional references who are ready to discuss your candidacy with us in great detail.


One essay is required –

  • What are your long term (5-10 years) career aspirations? How will the GHLP help you achieve these?


Shortlisted candidates might be required to go through an interview before they are accepted into the program. This interview may be conducted in person or over the telephone.

Key Dates

Round Deadline Date
Early Round 18th December, 2021

Please Note:

  • Considering the limited seats in the program and rolling admission process (first come – first serve), it is always more beneficial for candidates to apply as soon as possible. 
  • Your application can be placed on the waiting list. If you are not offered final admission for the current program, you might be offered a place in the next year’s program. In this case, your application fee will then be considered for the next year’s program. 
  • Application fee is refunded only in the case an applicant is not offered an admission to the program. 

The Program fee for GHLP is USD 30,000 inclusive of all taxes. It covers teaching fees, all academic materials, lunches and select dinners. The fee does not include transport expenses (domestic and international), any associated visa fees etc. and accommodation for modules and/or workshops.

Want to learn more before applying?

Please provide us some information, our program team will help you decide if GHLP is the right program for you.

Get more information


    By using this form you agree with the storage and handling of your data by this website.

    Back To Top